CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma
M. M. Cho, L. Song, A. E. Quamine, F. Szewc, L. Shi, J. D. Ebben, D. P. Turicek, J. M. Kline, D. M. Burpee, E. O. Lafeber, M. F. Phillips, A. S. Ceas, A. K. Erbe, C. M. Capitini
This study shows CD155 blockade with allogeneic NK cell infusion improves survival against osteosarcoma in mice, with benefits mediated through DNAM-1.
bioRxiv · Jun 7, 2023Cancer Biology